Vault-13

Kynam Capital Management, LP

PRINCETON, NJ · CIK 1907884 · 13F filing filed 2025-08-14

SEC-registered investment adviser since 2022 · limited partnership

As an employer

$928.8m reported value -20.5% vs Q1 2025
31positions
77.4%in top 10
3 new 4 added 21 reduced 3 sold out vs Q1 2025

Holdings, Q2 2025

The small lines show how much was held over the last 4 quarters (adjusted for stock splits).

#SecurityTickerShares Value% of portfolioChangeShares change
1 CELLDEX THERAPEUTICS INC NEW COM NEW CLDX CLDX 6,100,729 $124.1m13.37% 13.37% ReducedShares held: Q3 2024 3.5m, Q4 2024 5.1m, Q1 2025 6.5m, Q2 2025 6.1m -399.3k -399,271 -6.1%
2 VAXCYTE INC COM PCVX PCVX 3,071,588 $99.9m10.75% 10.75% ReducedShares held: Q3 2024 1.0m, Q4 2024 2.3m, Q1 2025 3.2m, Q2 2025 3.1m -128.4k -128,412 -4.0%
3 VERA THERAPEUTICS INC CL A VERA VERA 3,426,887 $80.7m8.69% 8.69% AddedShares held: Q3 2024 1.6m, Q4 2024 1.5m, Q1 2025 2.4m, Q2 2025 3.4m +1.0m +1,026,887 42.8%
4 SYNDAX PHARMACEUTICALS INC COM SNDX SNDX 8,520,000 $79.8m8.59% 8.59% UnchangedShares held: Q3 2024 5.8m, Q4 2024 8.5m, Q1 2025 8.5m, Q2 2025 8.5m
5 BIOCRYST PHARMACEUTICALS INC COM BCRX BCRX 8,463,742 $75.8m8.16% 8.16% ReducedShares held: Q3 2024 9.1m, Q4 2024 9.1m, Q1 2025 8.9m, Q2 2025 8.5m -464.8k -464,781 -5.2%
6 CG ONCOLOGY INC COM CGON CGON 2,457,667 $63.9m6.88% 6.88% ReducedShares held: Q3 2024 1.8m, Q4 2024 2.5m, Q1 2025 2.6m, Q2 2025 2.5m -154.0k -153,995 -5.9%
7 VIRIDIAN THERAPEUTICS INC COM VRDN VRDN 4,427,927 $61.9m6.66% 6.66% ReducedShares held: Q3 2024 2.5m, Q4 2024 3.3m, Q1 2025 4.7m, Q2 2025 4.4m -272.1k -272,073 -5.8%
8 COGENT BIOSCIENCES INC COM COGT COGT 8,492,557 $61.0m6.56% 6.56% ReducedShares held: Q3 2024 9.2m, Q4 2024 9.1m, Q1 2025 9.1m, Q2 2025 8.5m -612.4k -612,443 -6.7%
9 BEAM THERAPEUTICS INC COM BEAM BEAM 2,417,647 $41.1m4.43% 4.43% ReducedShares held: Q3 2024 1.3m, Q4 2024 1.8m, Q1 2025 2.5m, Q2 2025 2.4m -100.5k -100,523 -4.0%
10 IMMUNOCORE HLDGS PLC ADS IMCR IMCR 976,267 $30.6m3.30% 3.30% ReducedShares held: Q3 2024 0, Q4 2024 1.2m, Q1 2025 1.7m, Q2 2025 976.3k -719.3k -719,309 -42.4%
11 WAVE LIFE SCIENCES LTD SHS 96663EUR 96663EUR 4,560,053 $29.6m3.19% 3.19% ReducedShares held: Q3 2024 4.9m, Q4 2024 4.9m, Q1 2025 4.9m, Q2 2025 4.6m -339.4k -339,444 -6.9%
12 TRAVERE THERAPEUTICS INC COM TVTX TVTX 1,540,691 $22.8m2.45% 2.45% ReducedShares held: Q3 2024 1.4m, Q4 2024 1.8m, Q1 2025 1.8m, Q2 2025 1.5m -262.1k -262,059 -14.5%
13 TYRA BIOSCIENCES INC COM TYRA TYRA 2,329,998 $22.3m2.40% 2.40% ReducedShares held: Q3 2024 467.9k, Q4 2024 530.5k, Q1 2025 2.4m, Q2 2025 2.3m -76.1k -76,069 -3.2%
14 DYNAVAX TECHNOLOGIES CORP COM NEW DVAX DVAX 2,145,319 $21.3m2.29% 2.29% ReducedShares held: Q3 2024 8.3m, Q4 2024 6.6m, Q1 2025 2.6m, Q2 2025 2.1m -475.5k -475,478 -18.1%
15 ENGENE HOLDINGS INC COM COM 4,994,090 $18.2m1.96% 1.96% UnchangedShares held: Q3 2024 1.7m, Q4 2024 5.0m, Q1 2025 5.0m, Q2 2025 5.0m
16 CULLINAN THERAPEUTICS INC COM CGEM CGEM 2,095,998 $15.8m1.70% 1.70% ReducedShares held: Q3 2024 0, Q4 2024 1.3m, Q1 2025 2.3m, Q2 2025 2.1m -242.6k -242,631 -10.4%
17 NURIX THERAPEUTICS INC COM NRIX NRIX 1,173,605 $13.4m1.44% 1.44% AddedShares held: Q3 2024 0, Q4 2024 0, Q1 2025 800.0k, Q2 2025 1.2m +373.6k +373,605 46.7%
18 RELAY THERAPEUTICS INC COM RLAY RLAY 2,887,014 $10.0m1.08% 1.08% ReducedShares held: Q3 2024 0, Q4 2024 1.0m, Q1 2025 3.1m, Q2 2025 2.9m -176.3k -176,278 -5.8%
19 AMARIN CORP PLC SPONSORED ADR AMRN AMRN 576,111 $9.3m1.01% 1.01% NewShares held: Q3 2024 0, Q4 2024 0, Q1 2025 0, Q2 2025 576.1k
20 UROGEN PHARMA LTD COM URGN URGN 656,573 $9.0m0.97% 0.97% AddedShares held: Q3 2024 0, Q4 2024 0, Q1 2025 25.0k, Q2 2025 656.6k +631.6k +631,573 2526.3%
21 CYTOMX THERAPEUTICS INC COM CTMX CTMX 2,154,413 $4.9m0.53% 0.53% NewShares held: Q3 2024 0, Q4 2024 0, Q1 2025 0, Q2 2025 2.2m
22 GERON CORP COM GERN GERN 3,456,318 $4.9m0.52% 0.52% ReducedShares held: Q3 2024 0, Q4 2024 0, Q1 2025 3.7m, Q2 2025 3.5m -203.2k -203,208 -5.5%
23 IRONWOOD PHARMACEUTICALS INC COM CL A IRWD IRWD 5,466,825 $3.9m0.42% 0.42% ReducedShares held: Q3 2024 3.7m, Q4 2024 4.7m, Q1 2025 5.8m, Q2 2025 5.5m -356.1k -356,113 -6.1%
24 CARIBOU BIOSCIENCES INC COM CRBU CRBU 3,067,774 $3.9m0.42% 0.42% ReducedShares held: Q3 2024 2.4m, Q4 2024 2.4m, Q1 2025 3.3m, Q2 2025 3.1m -201.4k -201,373 -6.2%
25 SUTRO BIOPHARMA INC COM COM 5,088,099 $3.6m0.39% 0.39% ReducedShares held: Q3 2024 2.1m, Q4 2024 3.6m, Q1 2025 5.4m, Q2 2025 5.1m -353.3k -353,348 -6.5%
26 DESIGN THERAPEUTICS INC COM DSGN DSGN 1,029,579 $3.5m0.37% 0.37% AddedShares held: Q3 2024 0, Q4 2024 0, Q1 2025 904.0k, Q2 2025 1.0m +125.6k +125,562 13.9%
27 PROQR THRAPEUTICS N V SHS EURO PRQR PRQR 1,649,462 $3.4m0.36% 0.36% ReducedShares held: Q3 2024 0, Q4 2024 1.8m, Q1 2025 1.8m, Q2 2025 1.6m -100.5k -100,538 -5.8%
28 EDGEWISE THERAPEUTICS INC COM EWTX EWTX 253,979 $3.3m0.36% 0.36% NewShares held: Q3 2024 0, Q4 2024 0, Q1 2025 0, Q2 2025 254.0k
29 BURNING ROCK BIOTECH LTD SPONSORED ADS BNR BNR 994,883 $3.1m0.34% 0.34% UnchangedShares held: Q3 2024 989.2k, Q4 2024 994.9k, Q1 2025 994.9k, Q2 2025 994.9k
30 LIQUIDIA CORPORATION COM NEW LQDA LQDA 200,047 $2.5m0.27% 0.27% ReducedShares held: Q3 2024 2.3m, Q4 2024 2.3m, Q1 2025 633.8k, Q2 2025 200.0k -433.8k -433,755 -68.4%
31 CLIMB BIO INC COM CLYM CLYM 1,028,341 $1.3m0.14% 0.14% ReducedShares held: Q3 2024 0, Q4 2024 547.0k, Q1 2025 1.0m, Q2 2025 1.0m -18.7k -18,659 -1.8%

Sold out since Q1 2025

SecurityTickerShares held beforeValue then
NATERA INC NTRA NTRA 1,167,570 $165.1m1.2m shares
LEGEND BIOTECH CORP LEGN LEGN 610,000 $20.7m610.0k shares
AMARIN CORP PLC 12,414,628 $5.6m12.4m shares

Stakes above 5%

Companies where this manager has reported owning more than 5% of a class of shares, on Schedule 13D (may seek influence) or 13G (passive): its latest filing for each, from 19 Dec 2024 on.

CompanyTickerStakeChange ScheduleLast filed
BURNING ROCK BIOTECH LTD 13G · filed 2026-05-15 14.0% +3.0 pts 13G 2026-05-15
SYNDAX PHARMACEUTICALS INC SNDX · 13G · filed 2025-02-14 SNDX 10.0%≈ $186.2m 13G 2025-02-14
CYTOMX THERAPEUTICS INC CTMX · 13G · filed 2026-08-14 CTMX 10.0% +3.1 pts 13G 2026-08-14
CELLDEX THERAPEUTICS INC NEW CLDX · 13G · filed 2026-08-14 CLDX 6.8% -2.0 pts 13G 2026-08-14
VIRIDIAN THERAPEUTICS INC VRDN · 13G · filed 2026-08-14 VRDN 5.7% +4.2 pts 13G 2026-08-14
SUTRO BIOPHARMA INC 13G · filed 2026-05-15 5.3% -1.2 pts 13G 2026-05-15
CULLINAN THERAPEUTICS INC CGEM · 13G · filed 2026-03-04 CGEM 5.3%≈ $56.7m new 13G 2026-03-04